Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

J Am Heart Assoc. 2020 Apr 7;9(7):e016219. doi: 10.1161/JAHA.120.016219. Epub 2020 Apr 1.
No abstract available

Keywords: ACEI/ARB; COVID‐19; SARS‐CoV‐2; angiotensin‐converting enzyme 2; cardiovascular disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Betacoronavirus
  • COVID-19
  • Cardiovascular Diseases*
  • Coronavirus Infections
  • Coronavirus*
  • Humans
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors